Rising Glioblastoma Cases and Unmet Needs Pushing Market Expansion
    Glioblastoma Multiforme (GBM) is the most aggressive and lethal form of brain cancer, with a poor prognosis and limited treatment options. Despite advancements in cancer research, the survival rate for GBM patients remains low, highlighting the urgent need for more effective therapies. The current standard of care includes surgery, radiation, and chemotherapy, but these treatments...
0 Comments 0 Shares 480 Views 0 Reviews